NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) to Present at Seventh Annual ARM Cell & Gene Therapy Investor Day in New York City

Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced that it will be presenting at the upcoming ARM Cell & Gene Therapy Investor Day, hosted by the Alliance for Regenerative Medicine, to be held in New York City on March 21, 2019. Unique to the medical and biotech communities, the investor conference focuses on fast-paced, concise presentations from more than 35 companies, consolidated to a one-day conference while allowing opportunities for one-on-one partnering with venture and strategic investors. Genprex’s presentation is scheduled for Thursday, March 21, at 2:30-2:45 p.m. EDT in the Main Bar Room of the Metropolitan Club, One East 60th Street, New York, NY 10022. “I’m looking forward to attending Cell & Gene Therapy Investor Day for the first time, with the opportunity to share information about Genprex’s mission and our gene therapy technologies,” Genprex President and COO Julien Pham, MD, MPH said in the news release. “With a wide array of companies and industry leaders all presenting in a single day, this conference enables us and the investment community to take the pulse of where the industry is heading. It is an incredible honor to be a part of this event.”

To view the full press release, visit http://nnw.fm/bHQ7E

About Genprex, Inc.

Genprex, Inc. is a clinical stage gene therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex(TM) immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. For more information, visit the company’s website at www.Genprex.com.

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

More News From digitalpressnetwork.com

Small blast in French city of Lyon wounds 7; cause unclear

May 24, 2019

LYON, France — An explosion Friday on a busy pedestrian street in the French city of Lyon injured seven people, local officials said. The cause of the blast that occurred in or outside a branch of the bakery chain Brioche Doree wasn't immediately clear, according to Kamel Amerouche, the regional authority's communications chief. Authorities couldn't confirm French media reports that a small package had exploded. The victims sustained leg injuries that weren't life-threatening, Amerouche told The Associated Press. Live television images showed the Brioche Doree sign intact and police vans and an ambulance on the street, which had been cordoned...

Missouri governor signs bill banning abortions at 8 weeks

May 24, 2019

JEFFERSON CITY, Mo. — Missouri Gov. Mike Parson on Friday signed a bill that bans abortions on or beyond the eighth week of pregnancy without exceptions for cases of rape or incest, making it among the most restrictive abortion policies in the nation. Under the law that comes into force Aug. 28, doctors who violate the eight-week cutoff could face five to 15 years in prison. Women who terminate their pregnancies cannot be prosecuted. A legal challenge is expected, although it's unclear when that might occur. The measure includes exceptions for medical emergencies, such as when there is a risk...

GOP conservative temporarily blocks $19B disaster bill

May 24, 2019

WASHINGTON — A House GOP conservative complaining of Washington's free-spending and opaque ways blocked a long-overdue $19 billion disaster aid bill on Friday, extending a tempest over hurricane and flood relief that has left the measure meandering for months. Texas Republican Chip Roy, a former aide to Texas firebrand Sen. Ted Cruz, objected to speeding the measure through a nearly empty chamber, also complaining that it does not contain any of President Donald trump's $4.5 billion request for dealing with a migrant refugee crisis on the U.S.-Mexico border. "It is a bill that that includes nothing to address the international...

CEOs get $800,000 pay raise, leaving workers further behind

May 24, 2019

NEW YORK — Did you get a 7% raise last year? Congratulations, yours was in line with what CEOs at the biggest companies got. But for chief executives, that 7% was roughly $800,000. Pay for CEOs at S&P 500 companies rose to a median of $12 million last year, including salary, stock and other compensation, according to data analyzed by Equilar for The Associated Press. The eight-figure packages continue to rise as companies tie more of their CEOs' pay to their stock prices, which are still near record levels, and as profits hit an all-time high last year due to...

US stocks rebound, but still face losses for the week

May 24, 2019

NEW YORK — U.S. stocks rebounded in morning trading on Wall Street Friday, but were still on track for a third straight week of losses. The market has been swaying between gains and losses all week as investors face the prospect that the trade war between the U.S. and China will drag on longer than anticipated. Trading has been volatile since the dispute escalated earlier this month, with both sides taking measures to raise tariffs on each other's goods. President Donald Trump said Thursday that he expects to meet with his Chinese counterpart Xi Jinping at a summit next month...

Weather, 20 December
Houston Weather
+7

High: +11° Low: -2°

Humidity: 83%

Wind: NNE - 7 KPH

Canberra Weather
+27

High: +27° Low: +17°

Humidity: 87%

Wind: W - 20 KPH

Roissy-en-France Weather
+6

High: +6° Low: -5°

Humidity: 87%

Wind: ENE - 7 KPH

Florence Weather
+9

High: +9° Low: +6°

Humidity: 97%

Wind: ENE - 17 KPH

Parga Weather
+7

High: +16° Low: +4°

Humidity: 100%

Wind: SE - 25 KPH